Cardiovascular Risk Perception and Wellness Perspectives in HIV-infected Adults
HIV 感染者的心血管风险认知和健康观点
基本信息
- 批准号:8846418
- 负责人:
- 金额:$ 13.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-26 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcute myocardial infarctionAddressAdoptedAdoptionAdultAerobicAffectAgeAmerican Heart AssociationAwardAwarenessBehaviorBehavior TherapyCardiovascular DiseasesChronicChronic DiseaseClinical TrialsComorbidityDevelopmentDiabetes MellitusDietDyslipidemiasEffectivenessElementsExerciseFeedbackFutureGeneral PopulationGoalsHIVHealthHealth behaviorHeartHigh PrevalenceHyperlipidemiaHypertensionIndividualInflammationInterventionInterviewKnowledgeLeadLifeLinkLiteratureLongevityManualsMentored Patient-Oriented Research Career Development AwardMentorsMetabolicModelingMorbidity - disease rateMotivationNursesObesityParticipantPatientsPerceptionPersonsPhasePhysical activityPilot ProjectsPrimary PreventionProcessProtocols documentationQualitative MethodsQualitative ResearchRandomizedRandomized Clinical TrialsRecommendationRelative (related person)ResearchResearch MethodologyResearch TrainingRiskRisk AssessmentRisk FactorsRoleScienceScientistSmokingStructureTechniquesTestingTreatment ProtocolsWorkaging populationarmbasebehavior changebrief advicecardiovascular disorder riskcardiovascular risk factorcareerexperiencegood diethealth beliefimprovedinnovationmortalitymotivated behaviormotivational enhancement therapyphosphoribosylanthranilate isomerasepreferencepublic health relevancerisk perceptionsatisfactionskillstheoriestherapy development
项目摘要
DESCRIPTION (provided by applicant): This three-year K23 research and training award will enable the PI to acquire the knowledge and skills needed to become an independent nurse scientist, with the long-term goal of conducting research to develop and implement innovative interventions that reduce cardiovascular risk and promote wellness in HIV-infected patients. Cardiovascular disease (CVD) has emerged as a major cause of morbidity and mortality (evidenced by a higher rate of acute myocardial infarction at younger ages) in persons living with HIV (PLWH) compared with uninfected individuals. PLWH have a higher prevalence of traditional CVD risk factors, as well as increased comorbidities, such as hypertension, diabetes, obesity, and hyperlipidemia. Given the role of CVD in HIV-infected patients' mortality, understanding CVD risk perception and risk factor knowledge, and developing tailored interventions is imperative. This project draws on the Health Belief Model to better understand how PLWH perceive their risk for CVD, and to develop a motivational interviewing (MI)-based intervention to improve not only CVD risk perception but also the adoption of health-promoting behaviors in PLWH. The specific aims of the study are to: 1) describe and explore perceptions of CVD risk and the likelihood, preferences, benefits, and barriers of adopting health-promoting behaviors; 2.a.) develop a treatment manual for an individually delivered CVD risk assessment and lifestyle modification management intervention, and, 2.b.) conduct a pilot study to test the feasibility and acceptability of the 2-session intervention. Phase 1 will include in-depth individul qualitative interviews with 30-40 PLWH. Phase 2.a. will include manual development, a pilot of the preliminary protocol with 8-10 PLWH, and manual revisions. Phase 2.b. will include a randomized 2-arm (intervention or brief advice) pilot clinical trial with 40 PLWH. The knowledge gained from this study will inform the future development of a full-scale randomized clinical trial
to examine the effectiveness of a tailored intervention to improve CVD risk perception, improve adoption of heart-healthy behaviors, and reduce CVD risk in HIV-infected patients. The proposed K23 research will contribute a missing and fundamental element to our understanding and management of CVD risk in HIV-infected patients. The PI will work with experienced mentors to build expertise in: (1) qualitative research methods and analyses; and, (2) intervention development and pilot testing. This K23 proposal addresses a key priority in HIV treatment science and will fully prepare the PI for a research career as an HIV intervention scientist.
描述(由申请人提供):这个为期三年的 K23 研究和培训奖将使 PI 能够获得成为独立护士科学家所需的知识和技能,其长期目标是开展研究以开发和实施创新干预措施,降低心血管风险并促进艾滋病毒感染者的健康。与未感染者相比,心血管疾病(CVD)已成为艾滋病毒感染者(PLWH)发病和死亡的主要原因(年轻时急性心肌梗塞的发病率较高)。 PLWH 传统 CVD 危险因素的患病率较高,并且高血压、糖尿病、肥胖和高脂血症等合并症也较多。鉴于 CVD 在 HIV 感染者死亡率中的作用,了解 CVD 风险认知和风险因素知识并制定量身定制的干预措施势在必行。该项目利用健康信念模型来更好地了解 PLWH 如何看待自己的 CVD 风险,并开发基于动机访谈 (MI) 的干预措施,不仅改善 CVD 风险认知,还改善 PLWH 采取健康促进行为。该研究的具体目的是: 1) 描述和探索对 CVD 风险的看法以及采取健康促进行为的可能性、偏好、益处和障碍; 2.a.) 为单独实施的 CVD 风险评估和生活方式改变管理干预制定治疗手册,并且 2.b.) 进行试点研究以测试 2 次干预的可行性和可接受性。第一阶段将包括对 30-40 名感染者进行深入的个人定性访谈。阶段 2.a。将包括手册开发、针对 8-10 名 PLWH 的初步方案试点以及手册修订。阶段 2.b。将包括一项针对 40 名感染者的随机 2 臂(干预或简短建议)试点临床试验。从这项研究中获得的知识将为全面随机临床试验的未来发展提供信息
旨在检查定制干预措施的有效性,以改善艾滋病毒感染者的心血管疾病风险认知、改善心脏健康行为并降低心血管疾病风险。拟议的 K23 研究将为我们理解和管理 HIV 感染者的 CVD 风险提供一个缺失的基本要素。 PI 将与经验丰富的导师合作,建立以下方面的专业知识:(1) 定性研究方法和分析; (2) 干预措施开发和试点测试。这项 K23 提案解决了 HIV 治疗科学的一个关键优先事项,并将为 PI 为 HIV 干预科学家的研究生涯做好充分准备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia Ann Cioe其他文献
Patricia Ann Cioe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patricia Ann Cioe', 18)}}的其他基金
Preloading with Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
对艾滋病毒呈阳性的吸烟者进行预负荷尼古丁替代疗法,以提高自我效能和戒烟尝试
- 批准号:
10253389 - 财政年份:2021
- 资助金额:
$ 13.23万 - 项目类别:
A Peer Navigator Model to Improve Quit Attempts, Quitline Use, and Smoking Cessation Rates among HIV-positive smokers
用于改善艾滋病毒阳性吸烟者的戒烟尝试、戒烟热线使用和戒烟率的同伴导航模型
- 批准号:
10016255 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Cardiovascular Knowledge, Risk Perception & Actual Risk in HIV-infected Patients
心血管知识、风险认知
- 批准号:
8150425 - 财政年份:2010
- 资助金额:
$ 13.23万 - 项目类别:
Cardiovascular Knowledge, Risk Perception & Actual Risk in HIV-infected Patients
心血管知识、风险认知
- 批准号:
8070984 - 财政年份:2010
- 资助金额:
$ 13.23万 - 项目类别:
相似国自然基金
FTO介导的m6A修饰调控Treg细胞衰老在老年急性心肌梗死后心室重塑中的作用及机制研究
- 批准号:82300335
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雅解毫命通过“肝-心轴”调控PI3K-Akt通路减轻急性心肌梗死的作用及机制研究
- 批准号:82360839
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Trim28调控ALDH2翻译后修饰在急性心肌梗死中的作用及机制
- 批准号:
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:
ALOX5-5-HETE介导铁死亡在急性心肌梗死残余炎症的机制研究
- 批准号:82300373
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多重急性心肌梗死生物标志物现场快速检测的干式免疫闭合式双极电化学发光传感技术的研究
- 批准号:32371554
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 13.23万 - 项目类别:
Leveraging a novel health records platform to predict the development of cardiovascular disease following kidney transplantation
利用新型健康记录平台预测肾移植后心血管疾病的发展
- 批准号:
10679322 - 财政年份:2023
- 资助金额:
$ 13.23万 - 项目类别:
Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality
查明美国全国心血管疾病死亡率停滞不前的原因
- 批准号:
10585800 - 财政年份:2023
- 资助金额:
$ 13.23万 - 项目类别:
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
- 批准号:
10576349 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别:
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
- 批准号:
10339915 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别: